For: | Khandpur S, Mishra P, Mishra S, Tiwari S. Challenges in predictive modelling of chronic kidney disease: A narrative review. World J Nephrol 2024; 13(3): 97214 [PMID: 39351189 DOI: 10.5527/wjn.v13.i3.97214] |
---|---|
URL: | https://www.wjgnet.com/2220-6124/full/v13/i3/97214.htm |
Number | Citing Articles |
1 |
Bing Zhang, Liufei Deng. Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1574693
|
2 |
Yan-ni Wang, Xin Wu, Qi-yan Shan, Qiao Yang, Xiao-yong Yu, Jian-hua Yang, Hua Miao, Gang Cao, Ying-yong Zhao. Acteoside-containing caffeic acid is bioactive functional group of antifibrotic effect by suppressing inflammation via inhibiting AHR nuclear translocation in chronic kidney disease. Acta Pharmacologica Sinica 2025; doi: 10.1038/s41401-025-01598-4
|
3 |
Jiawei Zhang, Xiangge Ren, Bing Li, Zhifen Zhao, Shoudao Li, Wensheng Zhai. Fecal microbiota transplantation is a promising therapy for kidney diseases. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1628722
|
4 |
Xingfu Ji, Guilin Jing, Haoqi Sun, Xuan Li, Xuexun Chen. Case report and literature review: IgG4-related tubulointerstitial nephritis coexistent with systemic lupus erythematosus. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1585351
|
5 |
Weiwei Li, Lumiao Chen, Linsen Jiang, Zhijian Zhang, Kai Song. The prognostic nutritional index as a predictor of cardiovascular and all-cause mortality in chronic kidney disease: a population-based analysis of NHANES data (1999–2018). Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1589173
|
6 |
Hao-Yu Feng, Yi-Qi Wang, Jianhua Yang, Hua Miao, Ying-Yong Zhao, Xiaojuan Li. Anthraquinones from Rheum officinale Ameliorate Renal Fibrosis in Acute Kidney Injury and Chronic Kidney Disease. Drug Design, Development and Therapy 2025; : 5739 doi: 10.2147/DDDT.S521265
|